The rising incidence of myasthenia gravis (MG) world-wide has largely been attributed to an increase in cases among older people. Results of a 4-year prospective study show an increased incidence among people over 65 years of age, although the overall incidence remained stable.
News News Daily digests from key neurology conferences, written by on-site medical journalists.